文献速递白血病淋巴瘤

P2RY8-CRLF2阳性儿童急性淋巴细胞白血病的基因组与转录组图谱

Genomic and transcriptional landscape of P2RY8-CRLF2-positive childhood acute lymphoblastic leukemia.
PubMed 文献 · Leukemia · 2016-11-30

该研究对41例主要克隆融合阳性(含19对匹配的诊断/复发配对)儿童急性淋巴细胞白血病进行全外显子组和RNA测序整合分析,发现76%诊断时存在JAK/STAT及RTK/Ras通路激活突变且复发时几乎全部出现,IKZF1改变在复发组占优势(P=0.001)并从36%增至58%,P2RY8-CRLF2在32%复发中丢失,提示IKZF1通过介导自我更新和骨髓龛归巢在复发中起突出作用。

要点

  • 76%诊断病例携带JAK/STAT或RTK/Ras通路激活突变,复发时几乎全部存在。
  • IKZF1改变在复发组占优势(P=0.001),匹配病例中从36%增至58%。
  • P2RY8-CRLF2在32%复发中丢失,提示其对复发并非必需。

核心结论

  • P2RY8-CRLF2对复发发展并非必需,IKZF1通过介导自我更新和骨髓龛归巢在复发中起突出作用。
  • 逆转异常IKAROS信号或其不同程序可能成为这些白血病的潜在治疗选择。

研究设计与样本

  • 对41例主要克隆融合阳性儿童急性淋巴细胞白血病病例(含19对匹配的诊断/复发配对)进行全外显子组和RNA测序整合分析。

主要发现

  • 76%的诊断病例检测到多种常为亚克隆且高度不稳定的JAK/STAT及RTK/Ras通路激活突变,几乎所有复发中均存在。
  • P2RY8-CRLF2在32%的复发中丢失,而所有其他影响淋巴发育(58%)和细胞周期(39%)的基因组改变保持稳定。
  • IKZF1改变在复发案例中占优势(P=0.001),在匹配病例中从初始36%增加至58%。
  • IKZF1的特定转录特征包括干细胞特征、淋巴分化受损迹象、黏着斑增强、缺氧通路激活、细胞周期失调和耐药性增加。

临床怎么用

  • 作者认为,逆转异常IKAROS信号或其不同程序在这些白血病中可能成为有吸引力的潜在治疗选择。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Children with P2RY8-CRLF2-positive acute lymphoblastic leukemia have an increased relapse risk. Their mutational and transcriptional landscape, as well as the respective patterns at relapse remain largely elusive. We, therefore, performed an integrated analysis of whole-exome and RNA sequencing in 41 major clone fusion-positive cases including 19 matched diagnosis/relapse pairs. We detected a variety of frequently subclonal and highly instable JAK/STAT but also RTK/Ras pathway-activating mutations in 76% of cases at diagnosis and virtually all relapses. Unlike P2RY8-CRLF2 that was lost in 32% of relapses, all other genomic alterations affecting lymphoid development (58%) and cell cycle (39%) remained stable. Only IKZF1 alterations predominated in relapsing cases (P=0.001) and increased from initially 36 to 58% in matched cases. IKZF1's critical role is further corroborated by its specific transcriptional signature comprising stem cell features with signs of impaired lymphoid differentiation, enhanced focal adhesion, activated hypoxia pathway, deregulated cell cycle and increased drug resistance. Our findings support the notion that P2RY8-CRLF2 is dispensable for relapse development and instead highlight the prominent rank of IKZF1 for relapse development by mediating self-renewal and homing to the bone marrow niche. Consequently, reverting aberrant IKAROS signaling or its disparate programs emerges as an attractive potential treatment option in these leukemias.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Vesely C, Frech C, Eckert C, et al. Genomic and transcriptional landscape of P2RY8-CRLF2-positive childhood acute lymphoblastic leukemia. Leukemia. 2016. PMID: 27899802. doi:10.1038/leu.2016.365

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。